Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Almost a week after the Apple faithful collectively gasped at the first evidence that the iPhone’s red “end call” button might soon be vacating its center position to take up residence one column to the right, it looks like it might have been mostly a false alarm.
Meta is under scrutiny for the way it has moderated reproductive health content. Women's health advocates say the social media giant has allowed male health content to flow more freely than content geared toward women and gender diversity.
Lynn Martin, president of the New York Stock Exchange, talks to Cheddar News about the bounceback of the IPO market, the future of artificial intelligence, and the strength NYSE continues to command in the world of investing.
